165 related articles for article (PubMed ID: 28105232)
21. TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma.
Lu W; Mengxuan Z; Ming R; Zixu G; Yong Z; Simin Z; Yang Y; Leqi Q; Kangjie S; Yanlin L; Jia F; Yiteng D; Chuanyuan W; Jianying G
J Oncol; 2022; 2022():1419179. PubMed ID: 36268276
[TBL] [Abstract][Full Text] [Related]
22. TRIP13 Functions in the Establishment of the Spindle Assembly Checkpoint by Replenishing O-MAD2.
Ma HT; Poon RYC
Cell Rep; 2018 Feb; 22(6):1439-1450. PubMed ID: 29425500
[TBL] [Abstract][Full Text] [Related]
23. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
Tao Y; Yang G; Yang H; Song D; Hu L; Xie B; Wang H; Gao L; Gao M; Xu H; Xu Z; Wu X; Zhang Y; Zhu W; Zhan F; Shi J
Oncotarget; 2017 Apr; 8(16):26718-26731. PubMed ID: 28157697
[TBL] [Abstract][Full Text] [Related]
24. TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Di S; Li M; Ma Z; Guo K; Li X; Yan X
Pathol Res Pract; 2019 Jun; 215(6):152415. PubMed ID: 31064720
[TBL] [Abstract][Full Text] [Related]
25. Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Rios Garcia M; Meissburger B; Chan J; de Guia RM; Mattijssen F; Roessler S; Birkenfeld AL; Raschzok N; Riols F; Tokarz J; Giroud M; Gil Lozano M; Hartleben G; Nawroth P; Haid M; López M; Herzig S; Berriel Diaz M
Adv Sci (Weinh); 2022 Oct; 9(29):e2104291. PubMed ID: 36031387
[TBL] [Abstract][Full Text] [Related]
26. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
28. Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma.
Xu H; Ma Z; Mo X; Chen X; Xu F; Wu F; Chen H; Zhou G; Xia H; Zhang C
J Cancer; 2022; 13(7):2226-2237. PubMed ID: 35517402
[TBL] [Abstract][Full Text] [Related]
29. [Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis].
Zhou KS; Zhang Q; Zhang WT; Liu YY; Wu SS; Zhou J; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2017 Jul; 38(7):618-622. PubMed ID: 28810332
[No Abstract] [Full Text] [Related]
30. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
Shi C; Yang X; Bu X; Hou N; Chen P
Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
[TBL] [Abstract][Full Text] [Related]
31. Pch2(TRIP13): controlling cell division through regulation of HORMA domains.
Vader G
Chromosoma; 2015 Sep; 124(3):333-9. PubMed ID: 25895724
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
33. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.
Zhang X; Zhou J; Xue D; Li Z; Liu Y; Dong L
Int J Biol Macromol; 2019 May; 129():227-232. PubMed ID: 30685303
[TBL] [Abstract][Full Text] [Related]
34. CYP24A1, AHR, CPEB4, TRIP13, and PIK3CA genes expression in colorectal cancer patients: novel diagnostic biomarkers.
El Nakib AM; Elsaeed M; Abdelsalam RA; Wafi K; Elekhnawy E; Alrouji M; Alsaleem M; Aljarba NH; Batiha GE; Negm WA; Mostafa SA
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7946-7955. PubMed ID: 37750623
[TBL] [Abstract][Full Text] [Related]
35. ERCC6L promotes cell growth and invasion in human colorectal cancer.
Xie Y; Yu J; Wang F; Li M; Qiu X; Liu Y; Qi J
Oncol Lett; 2019 Jul; 18(1):237-246. PubMed ID: 31289493
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of microRNA‑183‑5p inhibits the proliferation and invasion of colorectal cancer cells by inactivating the reticulocalbin‑2/Wnt/β‑catenin signaling pathway.
Wang G; Zhou J; Lu F; Qiu L; Xu L; Yang X; Miao Y
Mol Med Rep; 2019 May; 19(5):4475-4483. PubMed ID: 30896885
[TBL] [Abstract][Full Text] [Related]
37. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of thyroid hormone receptor-interacting protein 13 drives tumorigenesis and affects clinical outcome.
Dazhi W; Mengxi Z; Fufeng C; Meixing Y
Biomark Med; 2017 Jan; 11(1):19-31. PubMed ID: 27827544
[TBL] [Abstract][Full Text] [Related]
39. A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
Wang Y; Huang J; Li B; Xue H; Tricot G; Hu L; Xu Z; Sun X; Chang S; Gao L; Tao Y; Xu H; Xie Y; Xiao W; Yu D; Kong Y; Chen G; Sun X; Lian F; Zhang N; Wu X; Mao Z; Zhan F; Zhu W; Shi J
Cancer Res; 2020 Feb; 80(3):536-548. PubMed ID: 31732653
[TBL] [Abstract][Full Text] [Related]
40. miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene.
Muhammad S; Tang Q; Wei L; Zhang Q; Wang G; Muhammad BU; Kaur K; Kamchedalova T; Gang Z; Jiang Z; Liu Z; Wang X
Exp Ther Med; 2019 Jan; 17(1):260-272. PubMed ID: 30651791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
